Xu et al. [18] found that FOXD2-AS1 expression was related to tumor size, TNM stage, and lymphatic metastasis, but not to gender, age and differentiation, and overexpression of FOXD2-AS1 was correlated with a high risk of DFS in GC. Here, FOXD2 is linked to neoplasm.